Elagolix: How far can it go in the world of gynecology?

Danis RB; Rachel B. Danis

doi:10.1016/j.xfre.2023.04.002

Elagolix: How far can it go in the world of gynecology?

Danis RB, Rachel B. Danis

F&S reports · 2023 · vol. 4(2) , pp. 163–164 · doi:10.1016/j.xfre.2023.04.002 · PMID:37398614 · PMC10310958 · W4364380987

editorial OA: gold CC0

📄 Open PDF View on OpenAlex View on PubMed View at publisher

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This paper reviews the potential applications and limitations of elagolix, a GnRH antagonist, for managing gynecological conditions like endometriosis and uterine fibroids.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (7)

Does timing matter when initiating elagolix in a natural menstrual cycle? via openalex
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist via openalex
W2610244466 via openalex
W1963761453 via openalex
doi:10.1016/j.xfre.2023.03.006 via openalex
W6796314619 via openalex
W6801138792 via openalex

Source provenance

europepmc: last seen: 2026-08-16T09:21:09.727480+00:00
openalex: last seen: 2026-06-10T17:14:06.276822+00:00

License: CC0 · commercial use OK

[1] Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist 2017

[2] Does timing matter when initiating elagolix in a natural menstrual cycle? 2021